Connect with us
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

Meet Pfizer Board Member And Ex-Facebook Director Susan Desmond Hellmann



We recently reported on how the C.E.O. of Reuters also sits on Pfizer’s board of directors, and is a major shareholder of Pfizer.

According to an investigation by The National Pulse, another Pfizer board member, Susan Desmond Hellmann, was the ex-director for Facebook.

Sources also indicate that Hellmann was formerly the C.E.O. for The Gates Foundation.

These developments are clearly cause for concern due to the obvious conflict of interest these specific individuals pose to the integrity of objective, safe, and effective modern medicine.

How can we trust a powerful multinational drug conglomerate that also has ties to big tech, and in the case of Reuters—outright controls the media?

This is what we could find on Hellmann:

Excellent investigative reporting by The National Pulse found:

Hellman was appointed to the social media platform’s board in March 2013 and served as it Lead Independent Director from June 2015 until October 30th 2019, shortly before the first reported case of COVID-19.

Mark Zuckerberg, Facebook founder and CEO, said “Sue has been a wonderful and thoughtful voice on the board for six years, and I’m personally grateful to her for everything she has done for this company” in response to her departure.


Here is her bio taken directly from the Pfizer board of directors page:

Current Senior Advisor and Board member of the Bill & Melinda Gates Medical Research Institute. Former Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014 until 2020.

Prior to joining the Bill & Melinda Gates Foundation, she was the first female and ninth overall Chancellor of the University of California, San Francisco (UCSF), from 2009 until 2014, where she still serves as an adjunct professor.

From 1995 through 2009, Dr. Desmond-Hellmann was employed at Genentech where she served as President of Product Development from 2005 to 2009 overseeing pre-clinical and clinical development, business development and product portfolio management.

Prior to joining Genentech, Dr. Desmond-Hellmann was Associate Director, Clinical Cancer Research at Bristol-Myers Squibb Pharmaceutical Research Institute. Director of Facebook Inc. from 2013 to 2019 and Procter & Gamble from 2010 to 2017. Pfizer Director since 2020. Member of our Governance & Sustainability and Science and Technology Committees.


Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

If you love what we do, please consider a $1/month donation to keep us live! Thank you!

Join the TruthLion Nightly Newsletter ... for FREE!